Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Subcutaneous injection of immune proteins is well tolerated and safe, and is clinically suitable for all patients. Subcutaneous immunoglobulin is superior to intravenous immunoglobulin because it does not require intravenous access and reduces the need for prodrug therapy with glucocorticoids and antihistamines. Due to the reduction of global market participants and the time interval between plasma collection and product launch, the production of subcutaneous immunoglobulin becomes cumbersome and time-consuming, and if not managed properly, it will hinder the subcutaneous immunoglobulin market during the forecast period.
In July 2019, CSL announced that Xembify has been approved by the US Food and Drug Administration. This is a new 20% subcutaneous immunoglobulin product for the treatment of patients with idiopathic immunodeficiency 2 years and older.
The increase in the incidence of autoimmune diseases will help drive the growth of this market during the forecast period. The deepening of the aging population has led to an increase in the infectivity of the elderly population, and the prevalence of several diseases such as cancer, diabetes and neurological diseases is rising, which has driven the global demand for subcutaneous immunoglobulin market.
The report details the trend, potential and market size of Subcutaneous Immunoglobulins market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Subcutaneous Immunoglobulinsmarket, defines the market attractiveness level of Subcutaneous Immunoglobulins market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Subcutaneous Immunoglobulins industry, describes the types of Subcutaneous Immunoglobulins market, the applications of major players and the market size, and deeply analyzes the current situation of the global Subcutaneous Immunoglobulins market and the development prospects and opportunities of Subcutaneous Immunoglobulins industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Subcutaneous Immunoglobulins market in Chapter 13.
By Player:
Grifols
CSL
Shire (Baxalta)
By Type:
10% Purity
20% Purity
By End-User:
Primary Immunodeficiency
Secondary Immunodeficiency
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Subcutaneous Immunoglobulins Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Subcutaneous Immunoglobulins Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Subcutaneous Immunoglobulins Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Subcutaneous Immunoglobulins Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Subcutaneous Immunoglobulins Market Analysis and Outlook to 2022
-
7.1 Global Subcutaneous Immunoglobulins Consumption (2017-2022)
-
7.2 United States Subcutaneous Immunoglobulins Consumption (2017-2022)
-
7.3 Europe Subcutaneous Immunoglobulins Consumption (2017-2022)
-
7.4 China Subcutaneous Immunoglobulins Consumption (2017-2022)
-
7.5 Japan Subcutaneous Immunoglobulins Consumption (2017-2022)
-
7.6 India Subcutaneous Immunoglobulins Consumption (2017-2022)
-
7.7 South Korea Subcutaneous Immunoglobulins Consumption (2017-2022)
8 Region and Country-wise Subcutaneous Immunoglobulins Market Analysis and Outlook to 2028
-
8.1 Global Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
8.2 United States Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
8.3 Europe Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
8.4 China Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
8.5 Japan Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
8.6 India Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
-
8.7 South Korea Subcutaneous Immunoglobulins Consumption Forecast (2022-2028)
9 Global Subcutaneous Immunoglobulins Market Outlook by Types and Applications to 2022
-
9.1 Global Subcutaneous Immunoglobulins Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 10% Purity Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 20% Purity Consumption and Growth Rate (2017-2022)
-
9.2 Global Subcutaneous Immunoglobulins Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Primary Immunodeficiency Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Secondary Immunodeficiency Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Subcutaneous Immunoglobulins Market Outlook by Types and Applications to 2028
-
10.1 Global Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 10% Purity Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 20% Purity Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Primary Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Secondary Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Subcutaneous Immunoglobulins Import and Export Analysis (Top 5 Countries)
-
11.1 Global Subcutaneous Immunoglobulins Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Subcutaneous Immunoglobulins Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Subcutaneous Immunoglobulins Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Subcutaneous Immunoglobulins Market Competitive Analysis
-
14.1 Grifols
-
14.1.1 Grifols Company Details
-
14.1.2 Grifols Subcutaneous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Grifols Subcutaneous Immunoglobulins Product and Service
-
14.2 CSL
-
14.2.1 CSL Company Details
-
14.2.2 CSL Subcutaneous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 CSL Subcutaneous Immunoglobulins Product and Service
-
14.3 Shire (Baxalta)
-
14.3.1 Shire (Baxalta) Company Details
-
14.3.2 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Shire (Baxalta) Subcutaneous Immunoglobulins Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Subcutaneous Immunoglobulins
-
Figure Subcutaneous Immunoglobulins Picture
-
Table Global Subcutaneous Immunoglobulins Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Subcutaneous Immunoglobulins Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Subcutaneous Immunoglobulins Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Subcutaneous Immunoglobulins Consumption by Country (2017-2022)
-
Figure United States Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Table Europe Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure China Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Japan Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure India Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure South Korea Subcutaneous Immunoglobulins Consumption and Growth Rate (2017-2022)
-
Figure Global Subcutaneous Immunoglobulins Consumption Forecast by Country (2022-2028)
-
Figure United States Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Subcutaneous Immunoglobulins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 10% Purity Consumption and Growth Rate (2017-2022)
-
Figure Global 20% Purity Consumption and Growth Rate (2017-2022)
-
Figure Global Primary Immunodeficiency Consumption and Growth Rate (2017-2022)
-
Figure Global Secondary Immunodeficiency Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global 10% Purity Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 20% Purity Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Primary Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Secondary Immunodeficiency Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Subcutaneous Immunoglobulins Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Subcutaneous Immunoglobulins Export by Region (Top 5 Countries) (2017-2028)
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Subcutaneous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Subcutaneous Immunoglobulins Product and Service
-
Table CSL (Foundation Year, Company Profile and etc.)
-
Table CSL Subcutaneous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Subcutaneous Immunoglobulins Product and Service
-
Table Shire (Baxalta) (Foundation Year, Company Profile and etc.)
-
Table Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire (Baxalta) Subcutaneous Immunoglobulins Product and Service
-
